The Latest Cardiovascular Industry Statistics Explained
The global cardiovascular devices market size was valued at USD 40.8 billion in 2019.
The statistic states that the global market for cardiovascular devices, which includes a range of medical devices used for the diagnosis and treatment of cardiovascular diseases, was valued at $40.8 billion in 2019. This figure reflects the total revenue generated from the sales of various cardiovascular devices worldwide during that year. The market size includes products such as cardiac rhythm management devices, stents, catheters, and monitoring systems. The value of $40.8 billion indicates the significant demand for cardiovascular devices due to the high prevalence of cardiovascular diseases globally, highlighting the importance of these devices in managing and treating cardiovascular conditions.
By 2028, the cardiovascular device market is expected to reach over USD 69.3 billion.
The statistic indicates that the cardiovascular device market is forecasted to experience substantial growth, with a projected value exceeding USD 69.3 billion by the year 2028. This suggests an increasing demand for cardiovascular devices such as pacemakers, stents, and defibrillators due to factors such as an aging population, rising prevalence of cardiovascular diseases, technological advancements, and improving healthcare infrastructure. The significant market size forecasted for 2028 highlights the importance of the cardiovascular device industry in addressing the healthcare needs of individuals with heart-related conditions and signifies opportunities for companies operating in this sector to innovate and expand their market presence.
North America holds the highest market share in terms of revenue in the cardiovascular devices market.
The statistic indicates that North America has generated the highest revenue in the market for cardiovascular devices compared to other regions. This suggests that North America is a dominant player in the industry, likely due to factors such as advanced healthcare infrastructure, high prevalence of cardiovascular diseases, strong demand for innovative medical technologies, and significant investments in research and development. The region’s leadership in market share signifies a lucrative opportunity for cardiovascular device manufacturers and highlights the importance of focusing on the North American market to drive business growth and profitability in the industry.
The market for cardiac rhythm management devices is expected to reach around USD 14.7 billion by 2028.
The statistic indicates that the market for cardiac rhythm management devices is forecasted to grow to approximately USD 14.7 billion by the year 2028. This suggests a significant increase in the demand for these medical devices that are designed to monitor and regulate the heart’s electrical activity for patients with heart rhythm disorders. Factors contributing to this growth may include an aging population, rising prevalence of cardiovascular diseases, advancements in technology leading to more innovative and effective devices, and increasing awareness and access to healthcare services. This projection highlights a promising outlook for the cardiac rhythm management device market and underscores the importance of continued research and development in this field to meet the growing healthcare needs of the population.
17.9 million people die from Cardiovascular diseases (CVDs) annually, causing demands in the industry to increase.
The statistic that 17.9 million people die from Cardiovascular diseases (CVDs) annually indicates a significant global health burden. CVDs, including heart attacks and strokes, are among the leading causes of death worldwide. This statistic highlights the urgent need for increased resources, research, and healthcare services to address the escalating demands in the industry. The high mortality rate from CVDs underscores the importance of public health interventions, preventive measures, and improved access to healthcare services to combat this major health issue and reduce the number of deaths associated with cardiovascular diseases.
Nearly 56% of the global deaths due to heart diseases in 2019 were in Asia.
The statistic “Nearly 56% of the global deaths due to heart diseases in 2019 were in Asia” indicates that a substantial majority of deaths caused by heart diseases around the world occurred in the continent of Asia during the specified year. This high percentage suggests a significant burden of heart diseases within the Asian population, highlighting the need for targeted interventions and healthcare initiatives to address and reduce the prevalence of heart-related conditions in this region. The statistic underscores the importance of prioritizing cardiovascular health awareness, prevention, and treatment strategies in Asia to mitigate the impact of heart diseases on public health and overall mortality rates.
Valvular heart disease devices account for USD 6.2 billion of the industry’s market value.
The statistic ‘Valvular heart disease devices account for USD 6.2 billion of the industry’s market value’ indicates the significant financial contribution of valvular heart disease devices to the overall market of medical devices. This suggests that the market for devices dedicated to managing conditions related to heart valve problems is substantial, with a market value specifically attributed to valvular heart disease treatment reaching $6.2 billion. This statistic highlights the importance and demand for these devices in the healthcare industry, reflecting the prevalence and impact of valvular heart disease on patients and the healthcare system as a whole.
Stents accounted for 30.2% of the total interventional cardiology market in 2019.
In 2019, stents comprised 30.2% of the total interventional cardiology market, indicating that they were a significant component of the overall market for cardiac procedures. Stents are commonly used in cardiology to treat blockages in arteries and improve blood flow to the heart. The statistic suggests that a considerable portion of interventional cardiology procedures involved the insertion of stents during that year. This information highlights the importance and prevalence of stents as a treatment option for cardiovascular conditions within the field of interventional cardiology.
The Cardiac Surgery’s market share is projected to reach over USD 4 billion by 2028.
The given statistic indicates that the market share of the Cardiac Surgery industry is forecasted to exceed USD 4 billion by the year 2028. This means that the total value of the market for cardiac surgery services and products is expected to grow significantly over the coming years, reflecting increasing demand and potential growth opportunities within the industry. The projection suggests a positive outlook for businesses operating in the cardiac surgery sector, as well as potential for investments and advancements in technology, research, and healthcare services related to cardiac surgery.
The United States is the largest market for cardiovascular devices, accounting for about one-third of the total industry.
This statistic highlights the significant impact and dominance of the United States in the global market for cardiovascular devices. With the US accounting for approximately one-third of the total industry, it demonstrates the country’s substantial demand and consumption of such medical devices. This indicates a high prevalence of cardiovascular conditions in the US population, driving the need for advanced medical technologies and devices to diagnose, treat, and manage these health issues. The statistic underscores the importance of the US market for companies in the cardiovascular device industry and emphasizes the country’s position as a key player in shaping the innovation and development of cardiovascular technologies worldwide.
Philips holds the most significant market share in the cardiovascular industry at 25%.
The statistic stating that Philips holds the most significant market share in the cardiovascular industry at 25% indicates that out of all the companies operating in the cardiovascular industry, Philips has the largest portion of the market at the specified percentage. This suggests that Philips is a dominant player in the industry, outperforming competitors in terms of sales or revenue generated from cardiovascular products. A 25% market share means that one in every four cardiovascular products sold in the market is likely to be from Philips. This statistic highlights Philips’ strong position in the cardiovascular market, which may be a result of its brand reputation, product quality, pricing strategy, innovation, or other factors that have contributed to its success in capturing a significant share of the market.
Medtronic, Boston Scientific, Abbott many more are also key most prominent players in the cardiovascular device manufacturing market.
The statistic highlights that Medtronic, Boston Scientific, Abbott, and other companies are among the top and most influential players in the cardiovascular device manufacturing market. These companies are recognized for their significant presence and contributions in the development and production of medical devices used in treating cardiovascular conditions. By being prominent players, they have demonstrated expertise, innovation, and competitiveness in this sector, shaping the industry landscape and advancing healthcare outcomes for patients with heart-related issues. Their market leadership reflects their success in providing high-quality, cutting-edge cardiovascular devices and solutions to meet the evolving needs of healthcare providers and patients worldwide.
The Electrophysiology Devices market is projected to grow at a CAGR of 6% until 2028.
This statistic indicates that the Electrophysiology Devices market is expected to experience a Compound Annual Growth Rate (CAGR) of 6% from the current year until the year 2028. A CAGR of 6% implies a consistent and steady growth rate over the specified period. This projection suggests that the market for Electrophysiology Devices, which are used in procedures such as cardiac ablation to treat various heart conditions, is anticipated to expand steadily, reflecting potential advancements in technology, increased prevalence of cardiac disorders, and growing investments in healthcare infrastructure. This information can be valuable for stakeholders such as investors, healthcare organizations, and manufacturers to make informed decisions and strategies for capitalizing on market opportunities in the coming years.
The Latin America Cardiovascular Devices Market is expected to reach USD 11.9 billion by 2023.
This statistic indicates the projected growth for the cardiovascular devices market in Latin America, with an anticipated value of USD 11.9 billion by the year 2023. This forecast suggests a significant increase in the demand for cardiovascular devices, such as pacemakers, stents, and defibrillators, within the region due to factors like rising prevalence of cardiovascular diseases, improving healthcare infrastructure, and increasing awareness about cardiac health. The expected market value represents opportunities for companies operating in the healthcare industry to expand their presence in Latin America and cater to the growing needs of patients requiring cardiovascular interventions.
84 million people in the U.S have at least one type of CVD, leading to rise in demand for cardiovascular devices.
The statistic that 84 million people in the U.S. have at least one type of cardiovascular disease highlights the significant prevalence and impact of heart-related conditions in the country. This high number of affected individuals suggests a substantial burden on the healthcare system and emphasizes the urgent need for effective prevention, diagnosis, and treatment strategies. Consequently, the rising demand for cardiovascular devices can be attributed to the increasing number of individuals requiring medical interventions to manage or treat their cardiovascular conditions. This statistic underscores the importance of continued research, innovation, and investment in cardiovascular healthcare to address the growing needs of the population and improve overall outcomes for those affected by heart diseases.
The Cardiac Assist Devices market is expected to reach USD 2.3 billion by 2023.
The statistic “The Cardiac Assist Devices market is expected to reach USD 2.3 billion by 2023” indicates the projected total value of the global market for cardiac assist devices in terms of US dollars by the year 2023. This forecast suggests significant growth in the industry as demand for cardiac assist devices, which are used to support or replace the pumping function of a failing heart, continues to rise. The estimated market value serves as a key indicator for investors, healthcare providers, manufacturers, and policymakers to assess the market potential and plan strategies accordingly in the coming years.
The pacemaker device market is projected to grow at a CAGR of 3.3% between 2021 and 2026.
This statistic indicates that the pacemaker device market is expected to experience a compound annual growth rate (CAGR) of 3.3% over the period from 2021 to 2026. This implies that the market for pacemaker devices is forecasted to expand steadily at an average annual rate of 3.3% during this time frame. The CAGR provides a useful measure of growth that smoothens out fluctuations in the market and gives a more consistent view of overall growth prospects. The projected growth suggests that there is increasing demand for pacemaker devices, potentially driven by factors such as technological advancements, an aging population, and improving access to healthcare in various regions.
The cardiac surgery devices market in the United States is expected to grow by USD 283.8 million during 2021-2025.
The statistic indicates that the cardiac surgery devices market in the United States is projected to experience significant growth over the period between 2021 and 2025, with an expected increase in revenue of USD 283.8 million. This growth suggests a positive trend in the demand for cardiac surgery devices within the US market, likely fueled by factors such as technological advancements in medical devices, an aging population, increasing prevalence of cardiovascular diseases, and rising awareness about treatment options. The projected growth reflects opportunities for companies operating in this sector to capitalize on the expanding market potential and cater to the evolving needs of healthcare providers and patients seeking cardiac surgical solutions.
References
0. – https://www.www.marketresearchfuture.com
1. – https://www.www.marketstudyreport.com
2. – https://www.www.ibisworld.com
3. – https://www.www.cdc.gov
4. – https://www.www.who.int
5. – https://www.www.technavio.com
6. – https://www.www.gminsights.com
7. – https://www.www.globenewswire.com
8. – https://www.www.marketdataforecast.com
9. – https://www.www.mordorintelligence.com
10. – https://www.www.grandviewresearch.com
11. – https://www.www.prnewswire.com
12. – https://www.www.fortunebusinessinsights.com
